Trilobio, developer of whole laboratory automation solutions for advancing biology research, has introduced the first version of its comprehensive robotics, laboratory equipment and software platform at the Society for Laboratory Automation and Screening conference, SLAS2025, alongside pilot customer data, demonstrating the platform’s abilities in advancing research workflows.
Trilobio was founded to improve genetic engineering, synthetic biology and life science research processes by building robotic laboratory automation modules coupled with an application store to package and distribute laboratory protocols as code. The company is deploying fully automated laboratories that address data quality and reproducibility challenges to improve research inefficiencies, whereby it is estimated that 77% of biologists cannot reproduce their own or other’s research, despite latest advances in laboratory automation tools.
Roya Amini-Naieni, CEO and Co-founder, Trilobio comments: “Our platform is built by biologists for biologists. We’re pleased to be showcasing our platform for the first time at SLAS2025. We’ve built Trilobio from the perspective of the biologist, with the understanding that full-integration and automation can unlock the full potential of research. This has led us to develop a platform that lets biologists use our robots 30 minutes after unboxing, design research protocols in minutes (not days), and get access to these capabilities at an affordable price.”
The Trilobio platform comprises the Trilobot laboratory robot, research devices (gripper, pipettes, and tube handlers), and the Trilobio OS research protocol software. It is purpose-built to ensure all research protocols designed and executed on the platform are reproducible in any other Trilobio-enabled laboratory. By facilitating whole laboratory operations to be automated, the company’s mission is to support biologists to maximise the potential of their research easily, accurately, and reliably. A key focus is overcoming the cost, complexity, configuration and training hurdles that prevent scientists from adopting automation more broadly.
Trilobio was co-founded by Roya Amini-Naieni and Maximilian Schommer in 2021, who were named on Forbes’ 30 Under 30 list for their contributions to advances in manufacturing and industry. To date, the company has raised US$3 million in a pre-seed round led by Argon Ventures and Lowercarbon Capital. The Trilobio platform is already deployed at leading biology laboratories and has generated validating data from initial pilot programmes.
The foundation of the Trilobio platform is the Trilobot, a multifunctional robot built on standardised hardware and software; enabling operation of any Trilobio research tool and intermodular collaboration between Trilobots to scale up research operations.
For more information about Trilobio’s platform, and to register interest, please visit: https://trilo.bio/.